The Competitive Landscape of Cancer Gene Therapy (2nd issue)BioSeeker Group ABMay 13, 2002 284 Pages - SKU: BIOS778540 |
Countries covered: United States
'The Competitive Landscape of Cancer Gene Therapy ' provides a complete and thorough description of the current cancer gene therapy pipelines. Further, it provides contact data, financial information, partnership activities, and descriptions about products in the pipeline for 44 companies active in the cancer field. A short description is also provided for 21 companies with close contact with the cancer gene therapy market. The report includes 125 companies with interest in the field, 148 pipeline therapies and 215 alliances. We also present a description and analysis of areas of development, trends, collaborations, indications, and clinical trial progress for the overall market. The report starts with a extensive section describing and analysing the gene delivery technologies. The report is a comprehensive information platform focusing on the latest developments in the field of cancer gene therapy. To assist you in grasping the material in the report we have generated 32 different tables and figures. Includes also extensive and descriptive figures of collaboration clusters. The report starts with a section that disecting different gene delivery systems and related companies. The conclusive section provides BioSeeker Group's comments and analysis on this material. Companies included: AlphaVax, ALZA Corp, AMDL Inc, Ark Therapeutics Ltd, Austrian Nordic Biotherapeutics AG, AVAX Technologies, Aventis RPR Gencell, Avigen Inc, Bavarian Nordic, Biogen, Biovector Therapeutics SA, BioVex, Calydon Inc, Cantab Pharmaceuticals, Cell Genesys, Chiron, Copernicus Therapeutics Inc, Cytogen, Genetix Pharmaceuticals Inc, Genetronics Inc, GenEra S.p.A, Genopoietic, Genotherapeutics Inc, GenStar Therapeutics, GenVec Inc, Genzyme Molecular Oncology Corp, Got-A-Gene AB, G.O.T. GmbH & Co. KG, Imgenex Corporation, Introgen Therapeutics Inc, ML Laboratories (Cobra Therapeutics), MainGen Biotechnologie, Mologen Holding AG, Northwest Biotherapeutics, Oxford BioMedica plc, ONYX Pharma, Oxxon Pharmaccines Ltd, Progenics Pharma, Schering (Canij), Supratek Pharma Inc, Targeted Genetics Corp, Therion Biologics, Titan Pharmaceuticals, Transgene, Valentis, Vical Inc.
|
More United States Oncology/Hematology Reports
2012 US Tumor Marker Testing Market Outlook: Growth Opportunities and Strategies by
Venture Planning Group
Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social ...
The 2012 Cancer Diagnostics Market: US, Europe, Japan - Emerging Opportunities and Business Expansion Strategies for Suppliers by
Venture Planning Group
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific ...
The 2012 US Cancer Diagnostics Market by
Venture Planning Group
This report presents a comprehensive analysis of the US cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, ...
The 2012 CA Tumor Markers: US, Europe, JapanTest Volume, Sales Forecasts and Supplier Shares by Country by
Venture Planning Group
The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific ...
Abraxane (Breast Cancer) - Analysis and Forecasts to 2020 by
GlobalData
Abraxane (Breast Cancer) - Analysis and Forecasts to 2020 Summary GlobalData’s pharmaceuticals report, “Abraxane (Breast Cancer) - Analysis and Forecasts to 2020” provides Abraxane sales forecasts for ...
See all reports like this >>
More United States Reports
e-Discovery Software Publishing in the US - Industry Market Research Report by
IBISWorld
e-Discovery Software Publishing in the US Finding growth : Electronic discovery (more often known as e-discovery) refers to a data search, location and securing process for use ...
D&B Country RiskLine Report: The United States of America by
Dun & Bradstreet Inc.
This D&B Country RiskLine Report will help you analyze the risks, opportunities and likely payment delays when doing business in this country. It includes ...
D&B Country Report: The United States of America by
Dun & Bradstreet Inc.
D&B Country Report. Comprehensive information for evaluating risks and opportunities when trading or investing in this country. Providing critical information and analysis on ...
Country Report United States January 2011 by
Economist Intelligence Unit
Country Reports analyse political and economic trends in featured countries. They show you exactly how national, regional and global events will affect your business in ...
Coal - US - a snapshot (2010) by
Mintel - Snapshots
Coal in US by Mintel Global Market Navigator provides you with annual year-end market size data, most recently updated in 2010. This market covers consumption ...
See all reports like this >>
Related Markets
Oncology/Hematology Reports
- Triple Analysis: Lymphoma, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Leukemia, Protein Kinase Inhibitors and Antibodies
- Triple Analysis: Breast Cancer, Protein Kinase Inhibitors and Antibodies
- Commercializing Biomarkers in Therapeutic and Diagnostic Applications
- Hematological Cancer Therapies